C6 pyridinium ceramide influences alternative pre-mRNA splicing by inhibiting protein phosphatase-1

Nucleic Acids Research

Volumn 40, Issue 9, 2012, Pages 4025-4039

  Sumanasekera, Chiranthani ^a   Kelemen, Olga ^a   Beullens, Monique ^b   Aubol, Brandon E ^c   Adams, Joseph A ^c   Sunkara, Manjula ^a   Morris, Andrew ^a   Bollen, Mathieu ^b   Andreadis, Athena ^d   Stamm, Stefan ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b LABORATORY OF MOLECULAR AND CELLULAR SIGNALING   (Belgium)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE DERIVATIVE; DEXTRO 2 N [6' (1 PYRIDINIUM)HEXANOYL]SPHINGOSINE BROMIDE; PHOSPHOPROTEIN PHOSPHATASE 1; PYRIDINIUM DERIVATIVE; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ARTICLE; CONTROLLED STUDY; DRF1 GENE; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EXON; EXON SKIPPING; GENE; GENETIC CONSERVATION; IN VITRO STUDY; LIPID COMPOSITION; POL BETA GENE; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN LIPID INTERACTION; PROTEIN MOTIF; SYK GENE; TAU GENE; TIAF1 GENE;

ALTERNATIVE SPLICING; BINDING SITES; CERAMIDES; ENZYME INHIBITORS; EXONS; HEK293 CELLS; HELA CELLS; HUMANS; PHOSPHORYLATION; PROTEIN PHOSPHATASE 1; PYRIDINIUM COMPOUNDS; RNA PRECURSORS; RNA, MESSENGER; RNA-BINDING PROTEINS;

EUKARYOTA;

EID: 84861372934     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkr1289     Document Type: Article

References (49)

1. Pan, Q., Shai, O., Lee, L.J., Frey, B.J. and Blencowe, B.J. (2008) Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat. Genet., 40, 1413-1415.
2. Tazi, J., Bakkour, N. and Stamm, S. (2009) Alternative splicing and disease. Biochim. Biophys. Acta, 1792, 14-26.
3. Novoyatleva, T., Heinrich, B., Tang, Y., Benderska, N., Butchbach, M.E., Lorson, C.L., Lorson, M.A., Ben-Dov, C., Fehlbaum, P., Bracco, L. et al. (2008) Protein phosphatase 1 binds to the RNA recognition motif of several splicing factors and regulates alternative pre-mRNA processing. Hum. Mol. Genet., 17, 52-70.
4. Shav-Tal, Y., Cohen, M., Lapter, S., Dye, B., Patton, J.G., Vandekerckhove, J. and Zipori, D. (2001) Nuclear relocalization of the pre-mRNA splicing factor PSF during apoptosis involves hyperphosphorylation, masking of antigenic epitopes, and changes in protein interactions. Mol. Biol. Cell, 12, 2328-2340. (Pubitemid 33051959)
5. Shin, C., Feng, Y. and Manley, J.L. (2004) Dephosphorylated SRp38 acts as a splicing repressor in response to heat shock. Nature, 427, 553-558. (Pubitemid 38209114)
6. Xiao, S.H. and Manley, J.L. (1997) Phosphorylation of the ASF/SF2 RS domain affects both protein-protein and protein-RNA interactions and is necessary for splicing. Genes Dev., 11, 334-344. (Pubitemid 27079911)
7. Chalfant, C.E., Rathman, K., Pinkerman, R.L., Wood, R.E., Obeid, L.M., Ogretmen, B. and Hannun, Y.A. (2002) De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells. Dependence on protein phosphatase-1. J. Biol. Chem., 277, 12587-12595. (Pubitemid 34952617)
8. Ghosh, N., Patel, N., Jiang, K., Watson, J.E., Cheng, J., Chalfant, C.E. and Cooper, D.R. (2007) Ceramide-activated protein phosphatase involvement in insulin resistance via Akt, serine/arginine-rich protein 40, and ribonucleic acid splicing in L6 skeletal muscle cells. Endocrinology, 148, 1359-1366.
9. Ledeen, R.W. and Wu, G. (2008) Nuclear sphingolipids: metabolism and signaling. J. Lipid Res., 49, 1176-1186.
10. Massiello, A., Salas, A., Pinkerman, R.L., Roddy, P., Roesser, J.R. and Chalfant, C.E. (2004) Identification of two RNA cis-elements that function to regulate the 50 splice site selection of Bcl-x pre-mRNA in response to ceramide. J. Biol. Chem., 279, 15799-15804. (Pubitemid 38509266)
11. Senkal, C.E., Ponnusamy, S., Rossi, M.J., Sundararaj, K., Szulc, Z., Bielawski, J., Bielawska, A., Meyer, M., Cobanoglu, B., Koybasi, S. et al. (2006) Potent antitumor activity of a novel cationic pyridinium-ceramide alone or in combination with gemcitabine against human head and neck squamous cell carcinomas in vitro and in vivo. J. Pharmacol. Exp. Ther., 317, 1188-1199. (Pubitemid 43764124)
12. Separovic, D., Saad, Z.H., Edwin, E.A., Bielawski, J., Pierce, J.S., Buren, E.V. and Bielawska, A. (2011) C16-ceramide analog combined with Pc 4 photodynamic therapy evokes enhanced total ceramide accumulation, promotion of DEVDase activation in the absence of apoptosis, and augmented overall cell killing. J. Lipids, 2011, 713867.
13. Chalfant, C.E., Kishikawa, K., Mumby, M.C., Kamibayashi, C., Bielawska, A. and Hannun, Y.A. (1999) Long chain ceramides activate protein phosphatase-1 and protein phosphatase-2A. Activation is stereospecific and regulated by phosphatidic acid. J. Biol. Chem., 274, 20313-20317.
14. Kishore, S., Khanna, A. and Stamm, S. (2008) Rapid generation of splicing reporters with pSpliceExpress. Gene, 427, 104-110.
15. Beullens, M., Van Eynde, A., Stalmans, W. and Bollen, M. (1992) The isolation of novel inhibitory polypeptides of protein phosphatase 1 from bovine thymus nuclei. J. Biol. Chem., 267, 16538-16544.
16. Sullards, M.C., Allegood, J.C., Kelly, S., Wang, E., Haynes, C.A., Park, H., Chen, Y. and Merrill, A.H. Jr (2007) Structure-specific, quantitative methods for analysis of sphingolipids by liquid chromatography-tandem mass spectrometry: "inside-out" sphingolipidomics. Methods Enzymol., 432, 83-115.
17. Pamuklar, Z., Federico, L., Liu, S., Umezu-Goto, M., Dong, A., Panchatcharam, M., Fulerson, Z., Berdyshev, E., Natarajan, V., Fang, X. et al. (2009) Autotaxin/lysopholipase D and lysophosphatidic acid regulate murine hemostasis and thrombosis. J. Biol. Chem., 284, 7385-7394.
18. Massiello, A. and Chalfant, C.E. (2006) SRp30a (ASF/SF2) regulates the alternative splicing of caspase-9 pre-mRNA and is required for ceramide-responsiveness. J. Lipid Res., 47, 892-897. (Pubitemid 43764686)
19. Karahatay, S., Thomas, K., Koybasi, S., Senkal, C.E., Elojeimy, S., Liu, X., Bielawski, J., Day, T.A., Gillespie, M.B., Sinha, D. et al. (2007) Clinical relevance of ceramide metabolism in the pathogenesis of human head and neck squamous cell carcinoma (HNSCC): attenuation of C(18)-ceramide in HNSCC tumors correlates with lymphovascular invasion and nodal metastasis. Cancer Lett., 256, 101-111. (Pubitemid 47333333)
20. Separovic, D., Bielawski, J., Pierce, J.S., Merchant, S., Tarca, A.L., Bhatti, G., Ogretmen, B. and Korbelik, M. (2011) Enhanced tumor cures after Foscan photodynamic therapy combined with the ceramide analog LCL29. Evidence from mouse squamous cell carcinomas for sphingolipids as biomarkers of treatment response. Int. J. Oncol., 38, 521-527.
21. Venables, J.P., Klinck, R., Bramard, A., Inkel, L., Dufresne-Martin, G., Koh, C., Gervais-Bird, J., Lapointe, E., Froehlich, U., Durand, M. et al. (2008) Identification of alternative splicing markers for breast cancer. Cancer Res., 68, 9525-9531.
22. Stamm, S. (2002) Signals and their transduction pathways regulating alternative splicing: a new dimension of the human genome. Hum. Mol. Genet., 11, 2409-2416. (Pubitemid 35174704)
23. Andreadis, A. (2005) Tau gene alternative splicing: expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases. Biochem. Biophys. Acta, 1739, 91-103. (Pubitemid 40018532)
24. Chalfant, C.E., Ogretmen, B., Galadari, S., Kroesen, B.J., Pettus, B.J. and Hannun, Y.A. (2001) FAS activation induces dephosphorylation of SR proteins; dependence on the de novo generation of ceramide and activation of protein phosphatase 1. J. Biol. Chem., 276, 44848-44855.
25. Daoud, R., Mies, G., Smialowska, A., Oláh, L., Hossmann, K. and Stamm, S. (2002) Ischemia induces a translocation of the splicing factor tra2-beta1 and changes alternative splicing patterns in the brain. J. Neurosci., 22, 5889-5899. (Pubitemid 35387633)
26. Patton, J.G., Porro, E.B., Galceran, J., Tempst, P. and Nadal-Ginard, B. (1993) Cloning and characterization of PSF, a novel pre-mRNA splicing factor. Genes Dev., 7, 393-406. (Pubitemid 23139233)
27. Urban, R.J., Bodenburg, Y., Kurosky, A., Wood, T.G. and Gasic, S. (2000) Polypyrimidine tract-binding protein-associated splicing factor is a negative regulator of transcriptional activity of the porcine p450scc insulin-like growth factor response element. Mol. Endocrinol., 14, 774-782. (Pubitemid 32260491)
28. Akhmedov, A.T. and Lopez, B.S. (2000) Human 100-kDa homologous DNA-pairing protein is the splicing factor PSF and promotes DNA strand invasion. Nucleic Acids Res., 28, 3022-3030. (Pubitemid 30624091)
29. Liu, L., Xie, N., Rennie, P., Challis, J.R., Gleave, M., Lye, S.J. and Dong, X. (2011) Consensus PP1 binding motifs regulate transcriptional corepression and alternative RNA splicing activities of the steroid receptor coregulators, p54nrb and PSF. Mol. Endocrinol., 25, 1197-1210.
30. Hirano, K., Erdodi, F., Patton, J.G. and Hartshorne, D.J. (1996) Interaction of protein phosphatase type 1 with a splicing factor. FEBS Lett., 389, 191-194. (Pubitemid 26226497)
31. Bailey, T.L. and Elkan, C. (1994) Fitting a mixture model by expectation maximization to discover motifs in biopolymers. Proc. Int. Conf. Intell. Syst. Mol. Biol., 2, 28-36.
32. Smith, P.J., Zhang, C., Wang, J., Chew, S.L., Zhang, M.Q. and Krainer, A.R. (2006) An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers. Hum. Mol. Genet., 15, 2490-2508. (Pubitemid 44288702)
33. Stamm, S., Zhu, J., Nakai, K., Stoilov, P., Stoss, O. and Zhang, M.Q. (2000) An alternative-exon database and its statistical analysis. DNA Cell Biol., 19, 739-756. (Pubitemid 32011938)
34. Clery, A., Jayne, S., Benderska, N., Dominguez, C., Stamm, S. and Allain, F.H. (2011) Molecular basis of purine-rich RNA recognition by the human SR-like protein Tra2-beta1. Nat. Struct. Mol. Biol., 18, 443-450.
35. Jiang, Z., Tang, H., Havlioglu, N., Zhang, X., Stamm, S., Yan, R. and Wu, J.Y. (2003) Mutations in tau gene exon 10 associated with FTDP-17 alter the activity of an exonic splicing enhancer to interact with Tra2 beta. J. Biol. Chem., 278, 18997-19007. (Pubitemid 36799284)
36. Ray, P., Kar, A., Fushimi, K., Havlioglu, N., Chen, X. and Wu, J.Y. (2011) PSF suppresses tau Exon 10 inclusion by interacting with a stem-loop structure downstream of exon 10. J. Mol. Neurosci., 45, 453-466.
37. Kondo, S., Yamamoto, N., Murakami, T., Okumura, M., Mayeda, A. and Imaizumi, K. (2004) Tra2 beta, SF2/ASF and SRp30c modulate the function of an exonic splicing enhancer in exon 10 of tau pre-mRNA. Genes Cells, 9, 121-130. (Pubitemid 38312956)
38. Peng, R., Dye, B.T., Perez, I., Barnard, D.C., Thompson, A.B. and Patton, J.G. (2002) PSF and p54nrb bind a conserved stem in U5 snRNA. RNA, 8, 1334-1347.
39. Wang, J., Gao, Q.-S., Wang, Y., Lafyatis, R., Stamm, S. and Andreadis, A. (2004) Tau exon 10, whose missplicing causes frontotemporal dementia, is regulated by an intricate interplay of Cis elements and Trans factors. J. Neurochem., 88, 1078-1090. (Pubitemid 38280676)
40. Wymann, M.P. and Schneiter, R. (2008) Lipid signalling in disease. Nat. Rev. Mol. Cell Biol., 9, 162-176. (Pubitemid 351158917)
41. Michel, C.I., Holley, C.L., Scruggs, B.S., Sidhu, R., Brookheart, R.T., Listenberger, L.L., Behlke, M.A., Ory, D.S. and Schaffer, J.E. (2011) Small nucleolar RNAs U32a, U33, and U35a are critical mediators of metabolic stress. Cell Metab., 14, 33-44.
42. Janas, T. and Yarus, M. (2006) Specific RNA binding to ordered phospholipid bilayers. Nucleic Acids Res., 34, 2128-2136. (Pubitemid 44314210)
43. Siomi, H. and Siomi, M.C. (2009) RISC hitches onto endosome trafficking. Nat. Cell Biol., 11, 1049-1051.
44. Gibbings, D.J., Ciaudo, C., Erhardt, M. and Voinnet, O. (2009) Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat. Cell Biol., 11, 1143-1149.
45. Martin, T.F. (1998) Phosphoinositide lipids as signaling molecules: common themes for signal transduction, cytoskeletal regulation, and membrane trafficking. Annu. Rev. Cell. Dev. Biol., 14, 231-264. (Pubitemid 29001455)
46. Mermoud, J.E., Cohen, P. and Lamond, A.I. (1992) Ser/Thr-specific protein phosphatases are required for both catalytic steps of pre-mRNA splicing. Nucleic Acids Res., 20, 5263-5269.
47. Stamm, S. (2008) Regulation of alternative splicing by reversible phosphorylation. J.Biol. Chem., 283, 1223-1227.
48. Tanuma, N., Kim, S.E., Beullens, M., Tsubaki, Y., Mitsuhashi, S., Nomura, M., Kawamura, T., Isono, K., Koseki, H., Sato, M. et al. (2008) Nuclear inhibitor of protein phosphatase-1 (NIPP1) directs protein phosphatase-1 (PP1) to dephosphorylate the U2 small nuclear ribonucleoprotein particle (snRNP) component, spliceosome-associated protein 155 (Sap155). J. Biol. Chem., 283, 35805-35814.
49. Shepard, P.J. and Hertel, K.J. (2009) The SR protein family. Genome Biol., 10, 242.